Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Microgen Aptitude Modules Launch

15 Sep 2010 07:00

RNS Number : 6850S
Microgen PLC
15 September 2010
 



microgen

www.microgen.com

 

15 September 2010

 

 

 

MICROGEN LAUNCHES THREE NEW MICROGEN APTITUDE SOFTWARE MODULES

 

Microgen plc (Microgen' or 'the Group') today launches three new modules for its flagship Business Process Platform, Microgen Aptitude. The new modules provide substantial performance improvements on the already market-leading capability of Microgen Aptitude and maintain Microgen's position as the technology leader in this category. The modules build on the performance and functionality of Microgen Aptitude Version 3.0, introduced in June 2010.

 

The new Microgen Aptitude Version 3.0 Modules are:

 

Microgen Aptitude DBClarity - This new capability within Microgen Aptitude functionality positions Microgen at the forefront of the emerging technology of in-database analytics, providing substantial performance improvements to database-intensive applications. Through its graphical interface, Microgen Aptitude DBClarity addresses one of the major functional weaknesses of current in-database analytics which are written in the database language resulting in a lack of transparency and auditability for non-programmers. For the first time, a business will be able to address this weakness and develop high performance in-database analytical applications via a graphical interface thereby reducing operational risk, speeding up the analysis process and improving collaboration between the business and IT.

 

Microgen Aptitude PerformancePLUS - Building on the market leading performance of Microgen Aptitude Version 3.0, the Microgen Aptitude PerformancePLUS module delivers transaction processing speeds that are up to a further 30 per cent faster. Such speeds are critical in high-volume and complex transaction environments such as digital media and retail banking. This performance improvement is achieved by, amongst other leading edge developments, the adoption of Microgen's innovative fast enrichment process, for which a patent has been filed making a total of 12 patents now filed associated with the Microgen Aptitude technology.

 

Microgen Aptitude BPD & SOA Orchestration - This module enables SOA orchestration from entities within the Business Process Diagram (BPD) providing the ability to merge new and old technologies, such as the integration of cloud services with legacy systems to create an agile environment that can respond rapidly to the speed of business change. With Microgen Aptitude BPD & SOA Orchestration, both IT and business users can now build and deploy flexible applications quickly within a Service Orientated Architecture (SOA) environment.

 

These new modules for Microgen Aptitude maintain Microgen's technology leadership position at the forefront of high volume processing in complex transaction environments. Microgen's market-leading capability has been further extended in terms of both performance and functionality. Furthermore, in-database analytics are increasingly being adopted as a necessary development to increase performance of database-intensive applications and Microgen has addressed one of the major limitations of current market solutions.

 

Contacts

Martyn Ratcliffe, Chairman 01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, Financial Dynamics 020-7831-3113

Haya Herbert-Burns, Financial Dynamics

 

Copyright © 2010 Microgen plc All Rights Reserved Microgen ® Microgen plc Microgen Aptitude ® Microgen Aptitude Limited Microgen Aptitude - Patent Pending (Serial No: 1686466) & U.S. Patents Pending

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLLLFLRALISLII
Date   Source Headline
2nd Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 202512:12 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 202512:17 pmRNSTotal Voting Rights
29th May 20257:00 amRNSShare Buyback Programme Renewal
28th May 202511:50 amRNSResult of Annual General Meeting
28th May 20257:00 amRNSAGM Statement and Board Appointment
23rd May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20252:47 pmRNSGrant of awards under the Aptitude 2020 DBP
1st May 202510:42 amRNSTotal Voting Rights
29th Apr 20257:00 amRNSNotice of 2025 Annual General Meeting
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20254:16 pmRNSExercise of awards under the Aptitude 2020 DBP
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSAptitude Fynapse New Contract Win
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202511:49 amRNSTotal Voting Rights
31st Mar 202510:29 amRNSNotification of Major Holdings
31st Mar 202510:11 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20255:01 pmRNSNotification of Major Holdings
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20255:10 pmRNSDirectorate Change
26th Mar 20257:00 amRNSAudited Results for Year Ended 31 December 2024
20th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20258:46 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.